Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Omnipharm Research International Inc
Profile last edited on: 5/17/18      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1991
First Award
1992
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

255 Great Arrow Avenue
Buffalo, NY 14207
   (716) 873-8140
   Dunnja@msn.com
   N/A
Location: Single
Congr. District: 26
County: Erie

Public Profile

Omnipharm Research International Inc produces drugs and treatments for skin disorders, and oral care

Extent of SBIR involvement

User Avatar
Phase I Awards
6
Phase II Awards
2
Conversion Rate
33.33%
Phase I Dollars
$549,019
Phase II Dollars
$1,249,528
Total Awarded
$1,798,547

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 1 NIH $99,510
Project Title: Novel Inhibitors of Chemical Absorption Through Skin
2002 1 NIH $100,000
Project Title: Topical Salicylanilides to Treat Diabetic Foot Ulcer
2001 2 NIH $849,131
Project Title: New Drugs For The Treatment Of Acne
2000 1 NIH $100,000
Project Title: Inhibition Of UV Induced Skin Cancer By Trifluorosal
1999 2 NIH $599,906
Project Title: New Salicylanilides for Control of Oral Disease

Key People / Management

  Joseph A Dunn -- President

  Robert A Coburn

  Kenneth Walters

Company News

There are no news available.